top of page

Collagen Biostimulation

As we age, the skin does not only develop wrinkles or lose volume. Collagen production, which plays an important role in skin firmness and structural support, also gradually declines over time.

 

Collagen biostimulators differ from traditional dermal fillers in that their primary purpose is not simply to add volume to a specific area, but to stimulate the skin’s own collagen-producing processes and support skin and tissue quality over time.

 

CaHA (calcium hydroxylapatite), PLLA (poly-L-lactic acid) and liquid PCL (polycaprolactone) are different biostimulatory materials used for this purpose.

 

The most appropriate biostimulator is selected according to the individual’s age, skin quality, degree of tissue loss, facial anatomy and treatment goals.

 
CaHA – Calcium Hydroxylapatite Collagen Biostimulation
​

CaHA is a biocompatible material containing calcium hydroxylapatite microspheres.

​

Depending on the product and the way it is used, CaHA may provide structural support to the tissues or, when diluted or hyperdiluted, may be used primarily to improve skin quality and stimulate collagen production.

As the carrier gel gradually breaks down, the CaHA microspheres are intended to support the formation of new collagen in the surrounding tissue.

​

When may CaHA be considered?
​
  • Reduced skin firmness

  • Loss of elasticity

  • Laxity in the lower face

  • Reduced definition of the facial oval

  • Thin skin prone to wrinkling

  • Reduced skin quality in the neck and décolletage

  • Signs of ageing on the backs of the hands

 
Which areas can be treated?
​

With appropriate patient selection and technique, CaHA may be used in areas such as:

​

  • Face

  • Lower face

  • Jawline area

  • Neck

  • Décolletage

  • Backs of the hands

 

The way CaHA is used, including its degree of dilution, may vary according to the treatment area and the desired effect.

 
PLLA – Poly-L-Lactic Acid Collagen Biostimulation
​

PLLA is a biocompatible and biodegradable material used to support collagen production within the skin and subcutaneous tissues over time.

 

One of the main differences between PLLA and conventional hyaluronic acid fillers is that much of the final result develops gradually rather than immediately after treatment.

 

Following PLLA treatment, a controlled biostimulatory process begins within the tissues. As new collagen formation is supported, gradual improvements may be seen in skin quality, firmness and, in some patients, overall structural support of the face.

​

When may PLLA be considered?
​
  • Age-related collagen loss

  • Reduced skin elasticity

  • Generalised loss of facial volume and tissue support

  • Laxity in the lower face

  • Gradual loss of facial contour definition

  • When improved skin firmness and quality are desired

 
When will I see results?
​

The effects of PLLA generally develop gradually.

For this reason, any initial fullness seen immediately after treatment does not represent the final result. The primary goal is to support the tissue’s own collagen production over time.

PLLA may be particularly suitable for patients who prefer gradual, natural-looking improvement rather than an immediate and dramatic change.

 
Liquid PCL – Polycaprolactone Collagen Biostimulation
​

PCL, or polycaprolactone, is a biocompatible and biodegradable polymer.

Liquid PCL biostimulatory treatments may be used to support the skin’s collagen-producing mechanisms and improve overall skin quality.

The primary goal is not to add volume to the face, but to support the structure, elasticity and firmness of the skin over time.

​

When may liquid PCL be considered?
​
  • Reduced skin quality

  • Loss of elasticity

  • Thin skin prone to wrinkling

  • Reduced definition of the facial oval

  • Loss of firmness in the lower face

  • Signs of ageing in the neck and décolletage

As with other collagen biostimulators, the results of PCL treatments generally develop gradually through biological processes within the tissue.

 
Are Collagen Biostimulators the Same as Dermal Fillers?

No.The main purpose of hyaluronic acid dermal fillers is to add volume and struc tural support to specific areas or to enhance facial contours.

With collagen biostimulators, the primary objective is to stimulate the tissue’s own collagen-producing mechanisms and support skin and tissue quality over time.

​

In other words, the aim of biostimulation is generally: “To support the tissue in rebuilding itself rather than simply filling the face.”

 

For some patients, dermal fillers and collagen biostimulators may be alternative approaches. For others, they may be used together within the same treatment plan to address different needs.

​

What Is the Difference Between CaHA, PLLA and PCL?

 

Although all three may be used for collagen biostimulation, they differ in composition, behaviour within the tissues and treatment protocols.

 
CaHA
​

Depending on how it is used, CaHA may provide both structural support and collagen biostimulation.

 

When diluted or hyperdiluted, the treatment may focus more on improving skin quality and firmness.

 
PLLA
​

PLLA is primarily used to stimulate gradual collagen production and improve tissue support over time.

 

The results develop progressively.

 
Liquid PCL
​

Liquid PCL is another biostimulatory option used to support collagen production and improve skin quality and elasticity.

 

There is no single answer as to which product is “best”. The most appropriate choice depends on the patient’s individual needs and the anatomical area being treated.

​

Frequently Asked Questions About Collagen Biostimulation
​
Who is a suitable candidate for collagen biostimulation?
​

Collagen biostimulation may be considered in suitable patients who are beginning to experience reduced skin firmness and elasticity, feel that their facial tissues have lost some of their previous support, or wish to maintain and improve overall skin quality. Age alone is not the deciding factor. Skin and tissue quality are more important.

 
At what age can collagen biostimulation be started?
​

Because collagen loss develops gradually with age, there is no single starting age that applies to everyone. The decision to begin treatment should be based more on the condition of the skin, tissue quality and the patient’s expectations than on chronological age alone.

 
How many sessions are needed?
​

There is no single standard protocol. Depending on the type of biostimulator used, the treatment area, the patient’s age, skin quality and desired outcome, treatment may consist of a single session or several sessions performed at specific intervals.

​

Are the results immediate?
​

A defining feature of collagen biostimulators is that the results generally develop gradually. Some products may cause temporary fullness or early changes immediately after treatment. However, sufficient time must be allowed for collagen production to occur before the true biostimulatory effect can be assessed. For this reason, results usually continue to develop over a period of weeks and months.

 
Will my face look swollen or overfilled?
​

The purpose of biostimulation is not to add excessive volume to the face.

With appropriate patient selection, the correct product and proper injection technique, the aim is to improve tissue quality without changing the patient’s natural facial character. Temporary swelling may occur immediately after treatment as a result of the injections or the solution used.

 
How long do the effects last?
​

The duration of the results depends on several factors, including the product used, the treatment protocol, the patient’s age, metabolism, skin characteristics and lifestyle. The effect of a biostimulator is not determined solely by how long the product itself remains in the tissue. The goal is to stimulate the patient’s own collagen production. For this reason, the duration of the effect may vary considerably from person to person.

​

Can I return to my normal routine after treatment?
​

Most people can return to their usual daily activities within a relatively short period of time. Temporary redness, tenderness, swelling or bruising may occur at the injection sites. Aftercare recommendations may vary according to the product used and the injection technique.

 
Is massage required after a biostimulator treatment?

 

The same rule does not apply to every biostimulator. With some PLLA treatments, the physician may recommend a specific massage protocol, while other products or techniques may not require massage at all. For this reason, patients should follow the specific aftercare instructions given by their treating physician rather than applying a general massage routine found online.

​

Can collagen biostimulators be dissolved?
​

Hyaluronic acid fillers can, when appropriate, be broken down using the enzyme hyaluronidase. CaHA, PLLA and PCL are not hyaluronic acid and cannot be dissolved with hyaluronidase. For this reason, careful product selection, accurate anatomical placement and appropriate injection technique are particularly important when using biostimulatory treatments.

 
Are there any side effects?
​

As with any injectable treatment, temporary redness, swelling, tenderness and bruising may occur. Less commonly, complications such as nodules, papules, inflammatory reactions, infection or other treatment-related adverse effects may develop. For this reason, it is important to assess the patient before treatment, understand the characteristics of the product being used and perform the procedure using appropriate anatomical and injection techniques.

​

Who should not have collagen biostimulation?
​

Treatment may not be suitable, or may need to be postponed, during pregnancy or breastfeeding, in the presence of active infection, active inflammatory or dermatological conditions in the treatment area, known hypersensitivity to the material being used, or certain systemic or autoimmune conditions. Suitability should be assessed individually following a medical history and clinical examination.

 
Which Collagen Biostimulator Is Right for Me?
​

There is no single collagen biostimulator that is “best” for everyone. For some patients, the main concern may be improving skin quality and elasticity. For others, loss of tissue support or changes in the facial oval may be more significant.

 

During consultation, factors such as:

​

  • Skin quality

  • Skin thickness

  • Degree of elasticity loss

  • Facial anatomy

  • Degree of volume loss

  • Treatment area

  • Individual ageing pattern

  • Previous aesthetic treatments

  • Patient expectations

 

are assessed together.

 

Based on these factors, CaHA, PLLA, liquid PCL or other treatments may be recommended either alone or in combination.

 

The aim is not to change the face or create unnecessary volume, but to support skin and tissue quality over time while preserving the patient’s natural facial identity.

bottom of page